TAYLOR RAMOS: Open Payments
NPI 1336754324 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 26 payments from 11 companies in 2025. Trend: 2023 $1,023 · 2024 $649 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $205 |
| Novo Nordisk Inc | 6 | $161 |
| PFIZER INC. | 2 | $134 |
| Astellas Pharma US Inc | 2 | $53 |
| Exact Sciences Corporation | 2 | $47 |
| Biogen, Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Exeltis, USA Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| CooperSurgical, Inc. | 1 | $14 |
Products named: Wegovy, VRAYLAR, ZAVZPRET, Veozah, Cologuard Collection Kit, UBRELVY, ZURZUVAE, Symbravo.
Industry payments across ID — which companies pay providers there.
